A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
NCT01685931
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
617
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Paliperidone Palmitate
Sponsor
Xian-Janssen Pharmaceutical Ltd.